Reuters logo
BRIEF-Versartis completes enrollment in phase 3 Velocity trial of Somavaratan in Pediatric GHD
August 22, 2016 / 1:06 PM / a year ago

BRIEF-Versartis completes enrollment in phase 3 Velocity trial of Somavaratan in Pediatric GHD

Aug 22 (Reuters) - Versartis Inc

* Announces completion of enrollment in phase 3 Velocity trial of Somavaratan in Pediatric GHD; line results are anticipated in q3 2017. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below